BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15814624)

  • 1. Increased mitochondrial DNA content in saliva associated with head and neck cancer.
    Jiang WW; Masayesva B; Zahurak M; Carvalho AL; Rosenbaum E; Mambo E; Zhou S; Minhas K; Benoit N; Westra WH; Alberg A; Sidransky D; Koch W; Califano J
    Clin Cancer Res; 2005 Apr; 11(7):2486-91. PubMed ID: 15814624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients.
    Jiang WW; Rosenbaum E; Mambo E; Zahurak M; Masayesva B; Carvalho AL; Zhou S; Westra WH; Alberg AJ; Sidransky D; Koch W; Califano JA
    Clin Cancer Res; 2006 Mar; 12(5):1564-9. PubMed ID: 16533782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial DNA content increase in response to cigarette smoking.
    Masayesva BG; Mambo E; Taylor RJ; Goloubeva OG; Zhou S; Cohen Y; Minhas K; Koch W; Sciubba J; Alberg AJ; Sidransky D; Califano J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):19-24. PubMed ID: 16434581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO.
    Kim MM; Glazer CA; Mambo E; Chatterjee A; Zhao M; Sidransky D; Califano JA
    Oral Oncol; 2006 Feb; 42(2):201-7. PubMed ID: 16266817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions.
    Kim MM; Clinger JD; Masayesva BG; Ha PK; Zahurak ML; Westra WH; Califano JA
    Clin Cancer Res; 2004 Dec; 10(24):8512-5. PubMed ID: 15623632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin.
    Lebrecht D; Kokkori A; Ketelsen UP; Setzer B; Walker UA
    J Pathol; 2005 Dec; 207(4):436-44. PubMed ID: 16278810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
    Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
    Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
    Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer.
    Zhao M; Rosenbaum E; Carvalho AL; Koch W; Jiang W; Sidransky D; Califano J
    Int J Cancer; 2005 Nov; 117(4):605-10. PubMed ID: 15929076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
    Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
    Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
    Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of numerical aberrations of chromosomes X and 11 and poor prognosis in squamous cell carcinomas of the head and neck.
    Xie X; Clausen OP; Boysen M
    Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):511-5. PubMed ID: 16702567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.